Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
6.59
-0.15 (-2.23%)
At close: Jul 3, 2025, 1:00 PM
6.54
-0.05 (-0.76%)
After-hours: Jul 3, 2025, 3:30 PM EDT
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $129.29 million as of July 3, 2025.
Market Cap
129.29M
Enterprise Value
125.40M
1-Year Change
n/a
Ranking
Category
Stock Price
6.59
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $129.29M, a decrease of -15.01%. That is a compound annual growth rate of -16.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2025 | 132.24M | -14.95% |
| Dec 31, 2024 | 155.47M | 2.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.81B |
| Johnson & Johnson | 367.53B |
| AbbVie | 327.88B |
| Novo Nordisk | 307.21B |
| UnitedHealth Group | 283.00B |
| Novartis AG | 236.92B |
| Abbott Laboratories | 236.64B |
| AstraZeneca | 215.00B |